Another way of saying this, if you enjoy smoking or vaping THC, consider vaping a 1:1 CBD:THC flower or oil.

For chronic THC users, the feeling of getting “high” becomes more and more elusive. This is due to our down-regulating or suppressing our CB-1 or Cannabinoid-1 receptors in our brain. This is another way of saying we become “tolerant” to the effects of THC. Patients go to dabs and other concentrates, but ultimately our CB-1 receptor gets hammered and more and more oil is “needed” and certainly used.

As there are some 1:1 or 2:1 CBD:THC strains out there, such as Harlequin and Omrita, with others to come, I have been hearing from patients how they feel.

1. They generally love it and love just having a different feeling of being High

2. They become more sensitive to THC; i.e. they up-regulate their CB-1 receptors.

3. They have less pain

4. They never get that THC anxiety feeling

5. Often more mood and clarity elevation

So, start asking your dispensaries to start carrying some CBD:THC balanced oils and flowers.

Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.